Filing Details

Accession Number:
0001181431-12-006613
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-07 19:33:52
Reporting Period:
2012-02-06
Filing Date:
2012-02-07
Accepted Time:
2012-02-07 19:33:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401923 Map Pharmaceuticals Inc. MAPP Pharmaceutical Preparations (2834) 200507047
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413822 Anastasios Gianakakos 2400 Bayshore Parkway, Suite 200
Mountain View CA 94043
Svp & Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-06 10,000 $6.39 22,385 No 4 M Direct
Common Stock Disposition 2012-02-06 10,000 $15.00 12,385 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-02-06 10,000 $0.00 19,382 $6.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-05-01 No 4 M Direct
Footnotes
  1. The sale of the reported shares is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares.
  2. The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on each monthly anniversary for 36 months so that the entire number of option shares becomes fully vested.